Stock Code 688278
中文 EN

Therapeutic areas ›

Molgramostim

Trade Name: Topleucon
Generic Name: Molgramostim (Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor, rHuGM-CSF)
Brief Introduction:
1. National Medical Insurance, Category B.
2. Launched in 1997.
3. The first China-made Molgramostim in market.
4. National standard bulk supplier of Molgramostim.

5.As an important immunomodulator of tumor vaccines, Topleucon

has participated in international clinical research in Europe in recent years.

The relevant research results have been published on international authoritative

tumor research platforms such as American Society of Clinical Oncology (ASCO) Annual Meeting.

Indications:
1.Treatment and prevention of leukopenia caused by radiotherapy or chemotherapy,
2.Treatment of bone marrow hematopoietic dysfunction and myelodysplastic syndrome,
3.Prevention of potential infection complications caused by leukopenia,
4.Accelerating recovery of neutrophils caused by infection
For details, please refer to Instructions.
Strengths:
50µg/vial, 75µg/vial, 100µg/vial, 150µg/vial, 300µg/vial, 400µg/vial


Product description download:Molgramostim.pdf

  • Tel:86 592 6889105/108

    Email: bd.amoytop@gmail.com / international@amoytop.com

    Add:No. 330 Wengjiao Road, Haicang, Xiamen, Fujian, China

  • Join Us:0592-7701210

    Email:hr@amoytop.com

  • Adverse Events Tel:86-592-6889111

    Adverse Events Email:fk@amoytop.com